Fidelity Investments
OKUR

Fidelity Investments’s OnKure Therapeutics OKUR Stock Holding History

Fidelity Investments’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406 Buy
+89
New +$382 ﹤0.01% 5330
2026
Q1 		– Sell
-400
Closed -$1.16K – 5601
2025
Q4 		$1.16K Buy
400
+350
+700% +$1.05K ﹤0.01% 5082
2025
Q3 		$138 Buy
+50
New +$124 ﹤0.01% 5180
2024
Q3 		– Sell
-1,262
Closed -$19.1K – 5767
2024
Q2 		$19.1K Buy
1,262
+1,101
+684% +$18.7K ﹤0.01% 4088
2024
Q1 		$2.66K Buy
161
+143
+794% +$2.36K ﹤0.01% 4645
2023
Q4 		$286 Sell
18
-18
-50% -$1.12K ﹤0.01% 4850
2023
Q3 		$2.76K Buy
36
+30
+500% +$2.04K ﹤0.01% 4463
2023
Q2 		$420 Buy
+6
New +$483 ﹤0.01% 4834
2022
Q2 		– Sell
-629
Closed -$18K – 5581
2022
Q1 		$18K Sell
629
-3,041
-83% -$170K ﹤0.01% 4058
2021
Q4 		$314K Sell
3,670
-15,080
-80% -$1.11M ﹤0.01% 2879
2021
Q3 		$1.4M Hold
18,750
– – ﹤0.01% 2638
2021
Q2 		$1.75M Buy
+18,750
New +$2.09M ﹤0.01% 2577

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's OKUR Position: Q2 2026 in Review

Fidelity Investments opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 89 shares worth $406. The stake represents ﹤0.01% of the portfolio and ranks #5330 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in OKUR as recently as Q4 2025.

Fidelity Investments first reported a position in OKUR in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.75M in Q2 2021. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Fidelity Investments held 89 shares of OnKure Therapeutics worth $406 as of Q2 2026.
  • OnKure Therapeutics was a new Fidelity Investments position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5330 holding.
  • Fidelity Investments first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Fidelity Investments's OnKure Therapeutics position peaked at $1.75M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.